for the Period Ended 31 March 2024
Balance sheet | |
Additional notes | |
Community Interest Report |
As at
Notes | 2024 | ||
---|---|---|---|
|
£ |
||
Fixed assets | |||
Intangible assets: |
|
||
Tangible assets: |
|
||
Investments: |
|
||
Total fixed assets: |
|
||
Current assets | |||
Stocks: |
|
||
Debtors: |
|
||
Cash at bank and in hand: |
|
||
Investments: |
|
||
Total current assets: |
|
||
Prepayments and accrued income: |
|
||
Creditors: amounts falling due within one year: |
|
||
Net current assets (liabilities): |
|
||
Total assets less current liabilities: |
|
||
Creditors: amounts falling due after more than one year: |
|
||
Provision for liabilities: |
|
||
Accruals and deferred income: |
|
||
Total net assets (liabilities): |
|
||
Members' funds | |||
Profit and loss account: |
|
||
Total members' funds: |
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 March 2024
Basis of measurement and preparation
for the Period Ended 31 March 2024
2024 | ||
---|---|---|
Average number of employees during the period |
|
Demand Diversity is a not-for-profit organisation dedicated to driving meaningful change within the clinical research industry by advocating for authentic diversity and inclusion. Over the financial year, the organisation has focused on identifying and addressing systemic barriers that prevent underrepresented populations from participating in clinical trials. This has been done through research, targeted campaigns, educational initiatives, and actionable guidance for stakeholders. Demand Diversity has worked to ensure that clinical trials reflect the diverse communities they are designed to serve. The organisation has collaborated closely with community groups to raise awareness about the importance of diversity in clinical trials, sharing evidence-based insights and practical strategies for improvement. By creating platforms for dialogue and delivering impactful advocacy, Demand Diversity has played a crucial role in catalysing action across the industry. The organisation’s activities have directly benefited the community by increasing the representation of underserved populations in clinical research. This ensures that medical advancements are more equitable and effective for all, helping to reduce health disparities and foster trust in healthcare systems among marginalised groups. By championing inclusivity, Demand Diversity has contributed to a broader societal shift towards fairness and equity in healthcare.
Demand Diversity recognises the critical importance of engaging with a wide range of stakeholders to advance diversity and inclusion within clinical research. Key stakeholders include underrepresented communities whose participation in clinical trials is essential for achieving comprehensive and equitable research outcomes, as well as clinical trial sponsors and researchers who design and implement studies. Healthcare providers, who play a vital role in patient care and recruitment for trials, are also central to these efforts, alongside policymakers and regulatory bodies that influence the guidelines governing clinical research. Advocacy groups and non-governmental organisations dedicated to health equity and patient rights further contribute to this ecosystem. Throughout the year, Demand Diversity has actively consulted its stakeholders through various methods. Community engagement initiatives, such as forums, workshops, and focus groups, have been integral in understanding the barriers faced by underrepresented populations. Collaborative partnerships with sponsors, researchers, and healthcare providers have provided valuable insights into the development of inclusive research protocols and recruitment strategies. Additionally, the organisation has worked closely with policymakers, advocating for regulatory frameworks that prioritise diversity. Surveys and feedback mechanisms have also been employed to gather perspectives from stakeholders, ensuring their voices shape the organisation’s strategic direction. In response to the feedback received, Demand Diversity has undertaken several impactful actions. Educational resources have been developed to raise awareness about the importance of diversity in clinical trials among both professionals and the public. Training programmes have been implemented to equip researchers and healthcare providers with the tools needed to engage with communities in culturally sensitive and effective ways. Communication channels have also been enhanced to foster ongoing dialogue with stakeholders, ensuring their continued involvement in shaping the organisation’s initiatives. These efforts have not only strengthened relationships with stakeholders but also enhanced the impact of Demand Diversity’s work in fostering inclusivity within clinical research. The consultations have ensured that the organisation’s strategies remain grounded in the needs and perspectives of those it serves.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
2 December 2024
And signed on behalf of the board by:
Name: Ashish Rishi
Status: Director